18 related articles for article (PubMed ID: 22421983)
1. Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice.
Stenman LK; Waget A; Garret C; Briand F; Burcelin R; Sulpice T; Lahtinen S
Diabetol Metab Syndr; 2015; 7():75. PubMed ID: 26366205
[TBL] [Abstract][Full Text] [Related]
2. Effects of incretin-based therapy in patients with heart failure and myocardial infarction.
Mikhail N
Endocrine; 2014 Sep; 47(1):21-8. PubMed ID: 24493030
[TBL] [Abstract][Full Text] [Related]
3. Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.
Gejl M; Lerche S; Mengel A; Møller N; Bibby BM; Smidt K; Brock B; Søndergaard H; Bøtker HE; Gjedde A; Holst JJ; Hansen SB; Rungby J
PLoS One; 2014; 9(1):e83758. PubMed ID: 24400077
[TBL] [Abstract][Full Text] [Related]
4. Incretin hormones as immunomodulators of atherosclerosis.
Alonso N; Julián MT; Puig-Domingo M; Vives-Pi M
Front Endocrinol (Lausanne); 2012; 3():112. PubMed ID: 22973260
[TBL] [Abstract][Full Text] [Related]
5. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.
Halbirk M; Nørrelund H; Møller N; Holst JJ; Schmitz O; Nielsen R; Nielsen-Kudsk JE; Nielsen SS; Nielsen TT; Eiskjaer H; Bøtker HE; Wiggers H
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1096-102. PubMed ID: 20081109
[TBL] [Abstract][Full Text] [Related]
8. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
9. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of short-term GLP-1 treatment in insulin resistant heart failure patients.
Nielsen R; Wiggers H; Halbirk M; Bøtker H; Holst JJ; Schmitz O; Frandsen E; Nielsen S; Møller N; Nørrelund H
Exp Clin Endocrinol Diabetes; 2012 May; 120(5):266-72. PubMed ID: 22421983
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
